🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
The purpose of this study is to test whether vaccination with antigenic pep...
Status
Completed
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Start Date
1999-05
Trial ID
NCT00112216
Treatments Being Tested
Background: * PSA (prostate specific antigen) is a protein found on normal...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-05-11
Trial ID
NCT00972309
The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Status
Terminated
Location
The Queen Elizabeth Hospital
Start Date
2025-06-16
Trial ID
NCT06692959
Treatments Being Tested
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2000-09
Trial ID
NCT00020358
Treatments Being Tested
This study evaluates whether it is safe to administer a peptide vaccine wit...
Status
Terminated
Location
Cancer Center at the University of Virginia
Start Date
2015-04
Trial ID
NCT02385669
Treatments Being Tested
This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2003-09-03
Trial ID
NCT00199836
Treatments Being Tested
To provide product through an expanded access program to HIV-infected patie...
Status
Completed
Location
Immune Response Corp
Start Date
TBD
Trial ID
NCT00002172
Treatments Being Tested
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested